Italy’s Menarini Diagnostics is to distribute the EpiCheck non-invasive bladder cancer urine test from Israel’s Nucleix (see here previously) in Europe. Bladder cancer is the sixth most common cancer as there are approximately 760,000 people in Europe with the disease.
Bladder cancer test goes to Europe
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.